EHA 2019 – turnaround puts Arqule in the takeover frame

EHA 2019 – turnaround puts Arqule in the takeover frame

Source: 
EP Vantage
snippet: 

A key update confirms ARQ 531 as the leading contender to treat patients who relapse on Imbruvica or Calquence.